Literature DB >> 14629480

Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo.

M N Abid Hussein1, E W Meesters, N Osmanovic, F P H Th M Romijn, R Nieuwland, A Sturk.   

Abstract

BACKGROUND: Endothelial activation and dysfunction are associated with several diseases. However, hardly any specific markers are available. Microparticles (MP) from endothelial cells (EC; EMP) were reported in patient groups and healthy individuals. The antibodies used to detect EMP, however, were mainly directed against antigens without EC specificity.
OBJECTIVES: We evaluated the antigens on EC and EMP to establish proper markers for EMP detection.
METHODS: EMP were isolated from supernatants of resting and interleukin (IL)-1alpha activated human umbilical vein EC (HUVEC; n=3; 0-72 h), stained with annexin V and monoclonal antibodies, and analyzed by flow cytometry. Human platelet-MP (PMP), the main MP population in plasma, were prepared in vitro. EMP and PMP were studied in plasma from systemic lupus erythematosus (SLE) patients (n=11) and healthy individuals (n=10).
RESULTS: Platelet-endothelial cell adhesion molecule-1 (PECAM-1), alphanu and beta3 were constitutively exposed on HUVEC, but (almost) absent on EMP (<15% positive for alphanu and beta3), or only exposed on a subpopulation (PECAM-1; 30-60%). Activated HUVEC (>80%) and (subpopulations of) EMP exposed E-selectin and tissue factor. PMP strongly exposed PECAM-1, beta3, and glycoprotein (GP)Ib (CD42b), but not alphanu or E-selectin. GPIb and P-selectin (CD62P) were absent on EMP. Plasma samples contained 0.5% MP staining for E-selectin and/or alphanu. Plasma from one SLE patient contained E-selectin exposing MP (21%), but little alphanu-positive MP.
CONCLUSIONS: EC release EMP in vitro. The antigenic phenotype of EMP released from resting and IL-1alpha-stimulated EC differs among each other as well as from resting and stimulated EC, respectively. E-selectin exposed on IL-1alpha-stimulated EC is a valid marker for EMP detection ex vivo to establish endothelial cell activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629480     DOI: 10.1046/j.1538-7836.2003.00455.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  32 in total

Review 1.  The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.

Authors:  Paolo Puddu; Giovanni M Puddu; Eleonora Cravero; Silvia Muscari; Antonio Muscari
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

2.  Impact of microparticles derived from erythrocytes on fibrinolysis.

Authors:  Grigory Levin; Ekaterina Sukhareva; Athina Lavrentieva
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

Review 3.  Extracellular vesicles and blood diseases.

Authors:  Shosaku Nomura
Journal:  Int J Hematol       Date:  2017-01-27       Impact factor: 2.490

Review 4.  Microparticles: new light shed on the understanding of venous thromboembolism.

Authors:  Lin Zhou; Xiao-long Qi; Ming-xin Xu; Yu Mao; Ming-lin Liu; Hao-ming Song
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

5.  Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.

Authors:  Eva Biró; Rienk Nieuwland; Paul P Tak; Loes M Pronk; Marianne C L Schaap; Augueste Sturk; C Erik Hack
Journal:  Ann Rheum Dis       Date:  2007-01-29       Impact factor: 19.103

Review 6.  Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.

Authors:  Sara C Sebag; Julie A Bastarache; Lorraine B Ware
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

7.  Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium.

Authors:  Kanagasabai Vadivel; Sayeh Agah; Amanda S Messer; Duilio Cascio; Madhu S Bajaj; Sriram Krishnaswamy; Charles T Esmon; Kaillathe Padmanabhan; S Paul Bajaj
Journal:  J Mol Biol       Date:  2013-02-20       Impact factor: 5.469

8.  High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.

Authors:  Antonella Caivano; Ilaria Laurenzana; Luciana De Luca; Francesco La Rocca; Vittorio Simeon; Stefania Trino; Fiorella D'Auria; Antonio Traficante; Maddalena Maietti; Tiziana Izzo; Giovanni D'Arena; Giovanna Mansueto; Giuseppe Pietrantuono; Luca Laurenti; Pellegrino Musto; Luigi Del Vecchio
Journal:  Tumour Biol       Date:  2015-07-09

9.  Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.

Authors:  Grace M Thomas; Laurence Panicot-Dubois; Romaric Lacroix; Françoise Dignat-George; Dominique Lombardo; Christophe Dubois
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

10.  Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.

Authors:  Julie A Bastarache; Richard D Fremont; Jonathan A Kropski; Frederick R Bossert; Lorraine B Ware
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-21       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.